Oligonucleotide Testing Market Size Worth $1,746.52 Million By 2024: Hexa Research

Thursday, April 5, 2018 Research News
Email Print This Page Comment bookmark
Font : A-A+

FELTON, California, April 5, 2018 /PRNewswire/ --

The global oligonucleotide testing market to reach

USD 1,746.52 million by 2024, owing to the increasing research and development activities in the field of oligonucleotide. For instance, nowadays, multifunctional oligonucleotide based aptamer molecules are widely studied biomedical class among
scientists across the globe. Due to its unique chemistry and potential advantages compared to currently available drugs (i.e. antibodies), aptamer became one of the most budding market for the future period.

With the rising concept of oligonucleotide as diagnostic, research and therapeutic agent, it is noticed that companies investigating the potential of oligonucleotide is going up. Number of small companies or start-ups entering the market is continuously increasing due to its potential advantages. Over the past few years, there has been explosive growth in number of research article published in the area of oligonucleotide and its products. According to the open access journal Multidisciplinary Digital Publishing Institute (MDPI AG), in 1995, there were not more than 200 research articles on aptamers. Compare to this, now it is around 1800 research literatures published by scientist on aptamer assays or therapeutics. This number indicates that companies focusing on the oligonucleotide drugs is rising every year. This fact would in turn cause a surge in demand for oligonucleotide testing services, augmenting growth. However, strict regulatory framework is anticipated to hamper the market expansion to some extent.

Types segment is categorized into Instrument, Software, and Services. Among which, instrument segment captured the largest share of the total market. Introduction of technological advanced chromatographic columns coupled with increasing demand for oligonucleotide synthesis drive the segment growth. Instrument segment is further divided into liquid chromatography, mass chromatography and capillary electrophoresis. In terms of application, the market is segmented as research and commercial. Research segment capture the largest share owing to the strong product pipeline.

Browse full research report with TOC on "Oligonucleotide Testing Market Size and Forecast By Type (Instrument (Liquid Chromatography, Mass Chromatography, Capillary Electrophoresis), Software, Service) By Application (Research, Commercial) And Trend Analysis, 2014 - 2024" at: https://www.hexaresearch.com/research-report/oligonucleotide-testing-market

In 2016, North America dominated the market contributing a share of more than 40% in the revenue generated worldwide. The primary reason being the high growth of this region, particularly in the U.S. is the rising research and development activities on oligonucleotides. Asia pacific region was estimated to be the fastest growing region in the global market and is anticipated to grow at a CAGR of about 10.8% by 2024. The growing need for effective therapeutics, rising awareness level, coupled with the favorable government initiatives are expected to drive growth in this region.

Currently there are very less approved oligonucleotide drugs namely fomivirsen (Vitravene), pegaptanib (Macugen), and mipomersen (Kynamro). Of which mipomersen and fomivirsen acti through RNase H mediated cleavage of targeted RNA. These drugs were developed by Ionis Pharmaceuticals. As the number of drugs available in the market are less, the oligonucleotide pipeline is strong and is expected to show positive response over the projection period.

Technological advances in development of oligonucleotide products has been one of the major market driver. Oligonucleotide synthesis has undergone tremendous changes which has resulted in rapid synthesis and cost-effective techniques of oligomer synthesis. Improvement of synthesis methods which include high throughput synthesizers, better coupling reagents and new sets of protective amino groups has drastically changed the nucleotide synthesis chemistry. With rapid development in oligonucleotide synthesis, the testing market is also expected to show lucrative growth. The major players are focusing on quality, service and innovation and adopting strategies such as product portfolio expansion, capacity expansions, and development of new facilities to gain market share.

Browse more reports by Hexa Research: 

  • Type 1 Diabetes Market - Global type 1 diabetes market size was valued at USD 25.52 billion in 2016 and is expected to exhibit rewarding growth over the forecast period. This is majorly due to the significant increase in type 1 diabetes (T1D) prevalence followed by rising uptake of novel formulations of insulin analogs and auxiliary therapies.
  • Herbal Medicine Market - Global herbal medicine market size was valued at USD 71.19 billion in 2016 and is expected to exhibit profitable growth over the forecast period. The increase is attributed to the increasing preference of consumers towards traditional medicines (Ayurveda, Unani and Traditional Chinese Medicine) which do not cause overdose toxicity and have fewer side effects.
  • Medical Morphine Market - Global medical morphine market size was valued at USD 10.75 billion in 2016. Increasing use of the drug to relieve pain in cancer, arthritis and postoperative surgeries is expected to drive market growth over the forecast period.

Hexa Research has segmented the global personal protective equipment market report based on product type, application and region: 

Segmentation by Type, 2014 - 2024 

    • Instrument

        • Liquid Chromatography

        • Mass Chromatography

        • Capillary Electrophoresis

    • Software

    • Service

Segmentation by application, 2014 - 2024 

    • Research

    • Commercial

Segmentation by region, 2014 - 2024 

    • North America

        • U.S.

    • Europe

        • Germany

        • UK

    • Asia Pacific

        • China

        • India

    • Rest of the world (RoW)

Key players analyzed: 

    • Thermo Fisher Scientific Inc.

    • Merck KGaA

    • Integrated DNA Technologies, Inc.

    • Agilent Technologies

    • Bruker

About Hexa Research 

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact: Michelle T. Corporate Sales Specialist Hexa Research Phone: +1-415-349-0058 Toll Free: 1-800-489-3075 Email: sales@hexaresearch.com

Web: https://www.hexaresearch.com/

SOURCE Hexa Research

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store